On Being Sane in Insane Places

Updated: 19 January 2018 David Rosenhan’s classic 1973 study remains one of the most important in the field of mental health. For all its faults – and there are a number of serious ones – it almost encapsulates the difficulties in trying to determine if someone is mentally ill. The last half of the 20th Century and the first decades of the 21st have witnessed virtual ‘epidemics’ of ‘mental illness’ inflicting themselves upon the Western world. These ‘epidemics’ have, in turn, spawned huge industries in mental health care and pharmacology – and there is increasing concern about the role of the pharmaceutical industry in influencing what is classified as mental illness and how such illnesses are treated. Lisa Cosgrove & Sheldon Krimsky’s 2012 expose is just one of many focusing on just how many of the authors of the Diagnostical & Statistical Manual of Mental Disorders – latest version DSM-5 (2015) – more and more have financial interests in the pharmaceutical industry. Thus, to some, it looks like the ORANGE vMEME’s desire for profit is driving changes in DSM – the medicalisation of mental illness that can be cured, or at least managed, by chemotherapy. Opponents to this direction tend to favour GREEN’s motif… Read More